Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Healio image

News from Healio

Stay current with all the latest and breaking news from Healio. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve aggregated 40 of Healio’s headlines and news stories over the past 3 months.

Healio’s media bias is Center. Ground News assigned this score by aggregating media bias ratings of a Center rating from Ad Fontes Media .

Healio’s factuality rating is Very High. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Healio

Where is Healio located?Healio's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byAd Fontes Media

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Healio News

US FDA approves Gilead's twice-yearly injection for HIV prevention

HIV · United States

US FDA approves Gilead's twice-yearly injection for HIV prevention

64% Center coverage: 262 sources

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among people given an injection every six months. See the Story

Kennedy's vaccine committee endorses preservative-free fall flu shots

Vaccines · United States

Kennedy's vaccine committee endorses preservative-free fall flu shots

49% Center coverage: 113 sources

The Advisory Committee on Immunization Practices (ACIP), recently remade by Health and Human Services Secretary Robert F. Kennedy Jr., voted Thursday in favor of only recommending flu shots that don’t contain the mercury-based preservative thimerosal. See the Story

CDC Nominee Susan Monarez Sidesteps Questions About Disagreements with RFK in Senate Hearing

CDC · United States

CDC Nominee Susan Monarez Sidesteps Questions About Disagreements with RFK in Senate Hearing

54% Center coverage: 107 sources

A key vaccine-focused committee of the Centers for Disease Control and Prevention met Wednesday despite bipartisan protestations and controversy that surrounds the group's membership.See the Story

Blindspots

CDC Nominee Susan Monarez Sidesteps Questions About Disagreements with RFK in Senate Hearing

CDC Nominee Susan Monarez Sidesteps Questions About Disagreements with RFK in Senate Hearing

CDC Nominee Susan Monarez Sidesteps Questions About Disagreements with RFK in Senate Hearing

Deaths From Heart Attacks Are Way Down. Here's What's Killing Us Instead

95% Center coverage: 38 sources

Heart disease deaths fell by 66% in 50 years, yet arrhythmia and heart failure rates are rising. Learn about the shifting trends in heart health.Obesity See the Story

Mifepristone Shown to Reduce A1C in Patients with Difficult-to-Control Type 2 Diabetes and Hypercortisolism

100% Center coverage: 10 sources

Study Results Signal Paradigm Shift in Diabetes Care for Patients with Difficult-to-Control Type 2 DiabetesDiabetes · United States See the Story

What the Science Says About Sunscreen

100% Center coverage: 2 sources

As temperatures climb and sleeves grow shorter, a familiar ritual returns: slathering on the sunscreen—or perhaps skipping it. Confusion lingers about how to protect our skin from the sun.Science See the Story

Inside Out: Regenerative Medicine for Recessive Dystrophic Epidermolysis Bullosa

80% Center coverage: 5 sources

Epidermolysis bullosa is classified as a genodermatosis, an inherited genetic skin disorder that results in severe, chronic skin blistering with painful and life-threatening complications. Although there is currently no cure for epidermolysis bullosa, concurrent advances in gene and stem cell therapies are converging toward combinatorial therapies that hold the promise of clinically meaningful and lifelong improvement. Recent studies using hemat…Gene Editing See the Story

Long-Lasting Insulin Takes Another Step Forward with Latest Clinical Trial Results

74% Center coverage: 30 sources

On Sunday in Chicago, Dr. Athena Philis-Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute in La Jolla, helped deliver positive news for the estimated 7 million Americans who take insulin every day to manage their type 2 diabetes. The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-…Novo Nordisk · Charleston See the Story

Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes

84% Center coverage: 19 sources

Common obesity drug reduced the risk of disease progression by 54%Medical · United States See the Story

Potential Medicaid Cuts Could Lead to More than 16,500 Medically-Preventable Deaths Each Year: Study

50% Center coverage: 16 sources

Medicaid · United States See the Story

[Opinion] ‘Back to Basics’: Universal Low-Dose Aspirin Can Be Beneficial for Preeclampsia Prevention

Coverage: 2 sources

MINNEAPOLIS — Universal presumption of low-dose aspirin, instead of risk-based screenings, can increase uptake for preeclampsia prevention in underserved populations, according to a speaker at the ACOG Annual Clinical & Scientific Meeting. “After one of our didactic sessions, I realized that a lot of our patients with preeclampsia met most of the eligibility criteria forOpinion · France See the Story

Breaking News Topics Related to Healio

Our use of cookiesCookie policy

Unlike other news sites, we do not share or sell your data to third-parties for targeted ads. In fact, the Ground News application and website do not run any ads at all. Our application and website use cookies and similar technologies to personalize content we deliver to you and also allows us to improve your usage of our platform through analytics. These cookies help us provide the best experience possible. Learn more about cookies and preference selection here.

By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.